Swedish Study Finds Money Hit by a Blood Disorder

Essential thrombocythemia, a rare blood disease, occurs in about 1.6 out of every 100,000 people in Sweden. It can cause bleeding or clotting problems and makes everyday tasks harder.

Researchers built a fiscal model that followed a group of patients with the disease and compared them to a similar group without it. They used Swedish records on jobs, earnings, sick days, disability and retirement, and they pulled health‑related data from published studies.

For a typical patient around 65 years old, the cost to the state was about SEK 1.7 million each year. Most of that came from lower tax income due to less work, plus extra spending on health care and social aid.

The biggest money hit is seen in younger patients who still have many years of work ahead, while older patients feel the weight mainly through higher medical bills.